Eagle Health Presents 50 New Traditional Chinese Medicine Products in China


Posted on August 9th, by Bourse Communications in News and Announcements. Comments Off on Eagle Health Presents 50 New Traditional Chinese Medicine Products in China

• Eagle Health presented 50 new Traditional Chinese Medicine (TCM) products at New Drug Trade Fair in China
• Eagle Health launch follows two years of development and regulatory approvals for TCM range
• 53rd China New Drug Trade Fair with 4000 exhibitors and 50,000 healthcare professionals
• Eagle Health also showcased “experience” store retail format

Eagle Health Holdings Limited (ASX: EHH) (“Eagle Health” or “Company”) is pleased to announce that on 3 August 2018, the Company presented its newly launched range of 50 Traditional Chinese Medicine (TCM) products and showcased its “Education and Experience” store format at the 53rd China New Drug Trade Fair (“New Drugs China”).

New Drugs China promotes the continuous development of China’s drug industry by opening communication channels for new drug research and development institutions, manufacturing companies, distribution companies and end customers. The three-day exhibition gathered well-known enterprises in the industry to showcase western medicines, proprietary Chinese medicines, biopharmaceuticals, over-the-counter medicines, contract customisation services, pharmaceutical distribution technology and equipment, and medical health services.

The Company has Fujian Province’s China Food and Drug Administration (Fujian CFDA) approval to manufacture and market the range of 50 TCM medicines that are being rolled out over the next three months. Respecting their origins and consumer preference to integrate TCM into their everyday life, these products can be included in food preparations or taken directly as directed by their Pharmacist or healthcare professional.

Mr Zhang Mingwang, CEO of Eagle Health, said:

“The Chinese Government has continued to support the development of TCM and the release of new variants such as our very successful Dendrobium based products. While TCM is well understood throughout China, it is often supplied at small retail outlets and hence we believe our consumer-friendly packaging and ease of access, like other modern pharmaceutical products, has the potential to revolutionise this category.

“In addition, Chinese consumers are changing the way they shop and buy health products. Our Direct experience stores show us that we can reach a very wide population and provide greater access to health education, product trial and on-going repeat purchases. We believe our direct-store and multi-channel approaches will not only provide consumers with the products they want but also ensure our products are more accessible for consumer to buy every day.”

The Eagle Health exhibition at New Drugs China also showcased the Company’s Education and Experience” direct retail format, which is also being rolled out along the East Coast of China. As announced on 31 May 2018, the Company plans to rollout 100 stores over the next 18 months with the potential to reach approximately 570 million consumers.

Within two years, Eagle Health’s organically certified TCM Dendrobium products have grown to be 13% of the Company’s AUD$89.2m sales for FY2017, which represents a 10.7% Year-on-Year (YoY) product sales’ growth. This growth has been driven by the recognised health benefits of the TCM ingredient Dendrobium and the convenient and accessible forms in which the popular TCM Dendrobium products are offered, including a powdered sachet product. The Company believes their success in Dendrobium is an indicator of the potential of the TCM products and will sell these products in their direct “Education and Experience” stores as well as Pharmacies and Pharmacy chains in China via the Company’s extensive distribution network.


Eagle Health’s “Education and Experience” store format showcased at New Drugs China, 3 August 2018


A selection of Eagle Health’s newly launched TCM preparations

About Eagle Health Holdings Limited

Eagle Health Holdings Limited is a vertically integrated consumer health and nutritional products business which develops, manufactures and distributes its product range across 26 provinces in China. Eagle Health produces a range of traditional Chinese and Western nutritional and dietary supplements including amino acids, protein supplements, lozenges and dendrobium. The Company distributes its products through a broad range of channels, including pharmacies, health food stores, trading companies, supermarkets and online stores.

For more information visit: www.auehh.com.au or www.eaglehealthltd.com/EN/index.aspx

For further information please contact:

Rod Hannington, Executive Director
Eagle Health Holdings Limited
T: +613 8593 7378
E: [email protected]

Rod North, Managing Director,
Bourse Communications Pty Ltd
T: +613 9510 8309, M: +61 408 670 706,
E: [email protected]





Comments are closed.